These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11815288)

  • 1. Annexin II: a plasminogen-plasminogen activator co-receptor.
    Kim J; Hajjar KA
    Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin II and regulation of cell surface fibrinolysis.
    Hajjar KA; Acharya SS
    Ann N Y Acad Sci; 2000 May; 902():265-71. PubMed ID: 10865846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin II: a mediator of the plasmin/plasminogen activator system.
    Hajjar KA; Krishnan S
    Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II and bleeding in acute promyelocytic leukemia.
    Menell JS; Cesarman GM; Jacovina AT; McLaughlin MA; Lev EA; Hajjar KA
    N Engl J Med; 1999 Apr; 340(13):994-1004. PubMed ID: 10099141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.
    Yang W; Mei FC; Cheng X
    FASEB J; 2018 Apr; 32(4):2212-2222. PubMed ID: 29217666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mediator of cell surface-specific plasmin generation.
    Brownstein C; Falcone DJ; Jacovina A; Hajjar KA
    Ann N Y Acad Sci; 2001 Dec; 947():143-55; discussion 155-6. PubMed ID: 11795262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of annexin II by homocysteine: implications for atherothrombosis.
    Hajjar KA; Jacovina AT
    J Investig Med; 1998 Oct; 46(8):364-9. PubMed ID: 9805420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
    Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
    Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
    Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
    Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.
    Gugliucci A; Ghitescu L
    Med Hypotheses; 2002 Sep; 59(3):247-51. PubMed ID: 12208147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elements of the fibrinolytic system.
    Lijnen HR
    Ann N Y Acad Sci; 2001; 936():226-36. PubMed ID: 11460480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells.
    Tabengwa EM; Abou-Agag LH; Benza RL; Torres JA; Aikens ML; Booyse FM
    Alcohol Clin Exp Res; 2000 Jun; 24(6):754-61. PubMed ID: 10888061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.